In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
about
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedsideBiology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsNovel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumanniiAntimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures.The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.Optimizing Polymyxin Combinations Against Resistant Gram-Negative BacteriaIn Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.Acinetobacter baumannii bacteremia, a rare complication of endoscopic retrograde cholagiopancreatography!Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii.Tigecycline: Alone or in combination?Correlation of Checkerboard Synergy Testing with Time-Kill Analysis and Clinical Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Respiratory Infections.Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.Multidrug resistant Acinetobacter baumannii reaches a new frontier: prosthetic hip joint infection.
P2860
Q27024893-1CEF2D5F-F818-4A97-9638-C81E534B21C9Q30235064-B3B77F72-B53F-4C92-BA9B-9106A7BFABBAQ35168931-9A6EFCE3-7A90-439F-B9EB-2EBFFED81834Q35314755-9EF47E73-A6E3-4C3A-94CB-54E0139C6800Q35432662-D074883B-EC50-44F0-B881-0BB06F841910Q36363261-D753C583-00D5-4C71-90E2-D749DDA42CE0Q36465442-9D457898-6A1B-4383-ABAE-14E556C3C351Q37715186-E85720AC-0E90-4489-B286-E0B42E261358Q37728145-4C6400BA-9DB9-47D1-852C-B25BFA533437Q39916184-8E9F678C-B278-465A-83AB-7178DBEBD940Q40575107-7D8BD9B6-51AA-4C02-BB82-6581BDF004C7Q40598620-F961F834-7F35-449E-877F-61A32C1C7AAFQ52407654-C1E8BD86-11E3-4C0C-8664-DBB1BA19D688Q53498472-D244EB1B-6569-467C-9F6B-7BAE1033512B
P2860
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
In vitro activity of doripenem ...... ment of complicated infection.
@en
In vitro activity of doripenem ...... ment of complicated infection.
@nl
type
label
In vitro activity of doripenem ...... ment of complicated infection.
@en
In vitro activity of doripenem ...... ment of complicated infection.
@nl
prefLabel
In vitro activity of doripenem ...... ment of complicated infection.
@en
In vitro activity of doripenem ...... ment of complicated infection.
@nl
P50
P356
P1476
In vitro activity of doripenem ...... ment of complicated infection.
@en
P2093
Alessandro Capone
Luigi Principe
P304
P356
10.1089/MDR.2012.0250
P577
2013-05-09T00:00:00Z